| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $354.5M | — | -4.1% |
| Cost of Revenue | $238.5M | — | -10.8% |
| Gross Profit | $116.0M | — | +13.4% |
| R&D Expense | $17.2M | — | -2.2% |
| SG&A Expense | $85.0M | — | -2.3% |
| Operating Income | $13.8M | — | +709.6% |
| Interest Expense | $1.7M | — | -36.8% |
| Pre-tax Income | $12.9M | — | +256.3% |
| Income Tax | -$157K | — | -107.6% |
| Net Income | $12.8M | — | +222.2% |
| EPS (Basic) | $0.11 | — | +210.0% |
| EPS (Diluted) | $0.11 | — | +210.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $178.4M | -23.7% | -18.6% |
| Inventory | $273.5M | -9.8% | -1.2% |
| Current Assets | $599.4M | -9.9% | -5.4% |
| Total Assets | $1.18B | -6.1% | -5.0% |
| Current Liabilities | $344.1M | -20.2% | -17.5% |
| Long-term Debt | $119.8M | -1.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $29.7M | — | +58.5% |
| Capital Expenditures | $3.7M | — | +19.4% |
| Investing Cash Flow | -$3.7M | — | -19.4% |
| Financing Cash Flow | -$5.3M | — | +76.1% |
| Free Cash Flow | $26.1M | — | +66.2% |
| -19.4% |
| Total Liabilities | $516.5M | -15.0% | -16.2% |
| Stockholders' Equity | $647.6M | +2.2% | +6.4% |